AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 35,121 | N/A | 32,342 | 34,662 | 31,180 |
| Marketable Securities | 60,228 | N/A | 77,993 | 100,868 | 122,933 |
| Receivables | 17,001 | N/A | 1,180 | 1,977 | 1,965 |
| Other current assets | 264 | 0 | 435 | 502 | 618 |
| TOTAL | $118,180 | $N/A | $116,744 | $142,126 | $159,778 |
| Non-Current Assets | |||||
| PPE Net | 2,428 | N/A | 2,401 | 2,759 | 3,018 |
| Investments And Advances | 740 | 0 | 705 | 730 | 708 |
| Intangibles | 63,791 | 0 | 60,852 | 62,995 | 61,114 |
| Other Non-Current Assets | 5,162 | 0 | 5,480 | 5,814 | 5,971 |
| TOTAL | $72,122 | $N/A | $69,438 | $72,297 | $70,812 |
| Total Assets | $190,302 | $N/A | $186,181 | $214,423 | $230,590 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,914 | 0 | 2,496 | 1,957 | 3,308 |
| Accrued Expenses | 9,012 | N/A | 9,737 | 14,985 | 13,911 |
| TOTAL | $126,832 | $N/A | $114,294 | $122,808 | $119,970 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 114,850 | N/A | 101,033 | 104,561 | 101,491 |
| Other Non-Current Liabilities | 15,635 | 0 | 14,888 | 10,217 | 15,657 |
| TOTAL | $18,971 | $N/A | $17,712 | $13,591 | $20,016 |
| Total Liabilities | $145,803 | $N/A | $132,006 | $136,399 | $139,986 |
| Shareholders' Equity | |||||
| Common Shares | 2,863 | N/A | 2,719 | 2,799 | 2,711 |
| Retained earnings | -569,942 | N/A | -529,898 | -524,479 | -493,316 |
| Other shareholders' equity | -258 | 0 | -255 | -269 | -259 |
| TOTAL | $44,499 | $N/A | $54,175 | $78,024 | $90,604 |
| Total Liabilities And Equity | $190,302 | $0 | $186,181 | $214,423 | $230,590 |